AstraZeneca (LSE:AZN), (NASDAQ:AZN), (NASDAQSTOCKHOLM:AZN) operates globally in the pharmaceutical and biopharmaceutical sector, focusing on the discovery, development, and commercialization of prescription medicines. The company's activities span a broad range of therapeutic areas, including oncology, cardiovascular, renal & metabolism, and respiratory & immunology, aiming to address significant unmet medical needs. AstraZeneca is known for its projects that push the boundaries of science to deliver life-changing drugs, with objectives centered around improving the health outcomes of millions of people worldwide. A cornerstone of its strategy involves robust research and development, strategic collaborations, and the integration of innovative technologies to enhance its pipeline and accelerate delivery of medical breakthroughs to patients.